BioCentury
ARTICLE | Clinical News

Caelyx pegylated liposomal doxorubicin regulatory update

February 5, 2001 8:00 AM UTC

AZA received approval in Canada for Caelyx to treat advanced ovarian cancer in women who have failed first-line platinum-based therapy. Caelyx, which also is approved in Canada to treat AIDS-related K...